125 related articles for article (PubMed ID: 10781661)
1. Comparison of the efficacy of two air-based contrast agents in dogs.
Uchimoto R; Niwa K; Tsuda N; Miyazawa T; Bräutigam M
Eur J Ultrasound; 2000 May; 11(2):127-33. PubMed ID: 10781661
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of myocardial perfusion with second harmonic imaging--using intravenous injection of Albunex and Levovist].
Hasegawa M; Saiki Y; Kayano H; Katagiri T
Nihon Rinsho; 1998 Apr; 56(4):903-8. PubMed ID: 9577606
[TBL] [Abstract][Full Text] [Related]
3. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular opacification after intravenous injection of Albunex. The effect of different administration procedures.
Sonne HS; Christensen PD; Muan B; Assentoft J; Haider T; Kristensen BO
Int J Card Imaging; 1995 Mar; 11(1):47-53. PubMed ID: 7730681
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
Leischik R; Beller KD; Erbel R
Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
[TBL] [Abstract][Full Text] [Related]
6. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
Yvorchuk KJ; Sochowski RA; Chan KL
J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular opacification by intravenous contrast echocardiography.
Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
[TBL] [Abstract][Full Text] [Related]
8. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
[TBL] [Abstract][Full Text] [Related]
9. Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs.
Wible JH; Wojdyla JK; Bales GL; McMullen WN; Geiser EA; Buss DD
J Am Soc Echocardiogr; 1996; 9(4):442-51. PubMed ID: 8827627
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
11. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex.
Gandhok NK; Block R; Ostoic T; Rawal M; Hickle P; Devries S; Feinstein SB
J Am Soc Echocardiogr; 1997; 10(1):25-30. PubMed ID: 9046490
[TBL] [Abstract][Full Text] [Related]
12. [Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose].
Vargas F; Hilbert G; Gruson D; Chene G; Journot V; Diebold B; Roudaut R
Arch Mal Coeur Vaiss; 2000 Jan; 93(1):41-7. PubMed ID: 11227717
[TBL] [Abstract][Full Text] [Related]
13. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography.
Keller MW; Glasheen W; Kaul S
J Am Soc Echocardiogr; 1989; 2(1):48-52. PubMed ID: 2627424
[TBL] [Abstract][Full Text] [Related]
14. Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacification.
Hausnerova E; Gottdiener JS; Gould JJ; Pezzullo JC; Callahan JD; Cohen JL; Bruns DE; Kuvelas MT; West HE; Dittrich HC
J Am Soc Echocardiogr; 1999 Nov; 12(11):957-66. PubMed ID: 10552357
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of left ventricular volume by contrast echocardiography].
Iwamori K; Ishikawa K
Nihon Rinsho; 1998 Apr; 56(4):926-9. PubMed ID: 9577610
[TBL] [Abstract][Full Text] [Related]
16. Effect of microsphere size distribution on the ultrasonographic contrast efficacy of air-filled albumin microspheres in the left ventricle of dog hearts.
Sontum PC; Walday P; Dyrstad K; Hoff L; Frigstad S; Chistiansen C
Invest Radiol; 1997 Oct; 32(10):627-35. PubMed ID: 9342123
[TBL] [Abstract][Full Text] [Related]
17. Optimizing albunex in the left ventricle: an analysis of the technical parameters of four ultrasound systems in canines and humans.
Block RJ; Brodsky L; Ostoic T; Fernandez A; Hickle P; Devries S; Bieniarz T; In M; Feinstein SB
J Am Soc Echocardiogr; 1996; 9(6):787-94. PubMed ID: 8943438
[TBL] [Abstract][Full Text] [Related]
18. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography].
Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M
J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037
[TBL] [Abstract][Full Text] [Related]
19. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P
Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046
[TBL] [Abstract][Full Text] [Related]
20. Intravenous albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders.
Falcone RA; Marcovitz PA; Perez JE; Dittrich HC; Hopkins WE; Armstrong WF
Am Heart J; 1995 Aug; 130(2):254-8. PubMed ID: 7631604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
